Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Diabetes and Endocrinology
Cardiology and CTVS
Medicine
SGLT-2 Inhibitors Reduce Adverse CV Outcomes Related To Intra-Stent Restenosis In Patients With Type 2 Diabetes
0 Comments
Post a comment
No comments yet. Be the first to comment!